Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antioxidant gene expression stimulation refers to the upregulation of genes encoding antioxidant enzymes and related cytoprotective proteins in response to oxidative or electrophilic stress. This process is primarily regulated at the transcriptional level by specific DNA elements and transcription factors, most notably the antioxidant response element (ARE) and its key regulator, nuclear factor erythroid 2–related factor 2 (Nrf2). Nrf2 is a master transcription factor that, upon activation by oxidative stress or electrophiles, translocates to the nucleus, binds to ARE sequences in the promoter regions of target genes, and increases their transcription. This results in increased expression of enzymes involved in detoxification, redox balance, and metabolism, protecting cells from oxidative damage. While beneficial, dysregulation of this pathway can have adverse consequences, such as chemoresistance in cancer cells.
Nrf2 activation leading to ARE-mediated transcription of antioxidant genes.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antioxidant Gene Expression Stimulation (AGES).